Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma - Quaterly Results
Date: 28-05-2025
The Revenue for the quarter ended March 2025 of Rs. 11574.00 millions grew by 19.96 % from Rs. 9648.00 millions.Net profit stood at Rs. 4281.00 millions compared to Rs. 3491.00 millions in the corresponding previous quarter,high by 22.63%.Operating profit surged to 6233.00 millions from the corresponding previous quarter of 4886.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 11574.00 | 9648.00 | 19.96 | 40945.00 | 35689.00 | 14.73 | 40945.00 | 35689.00 | 14.73 |
| Other Income | 621.00 | 359.00 | 72.98 | 3213.00 | 1047.00 | 206.88 | 3213.00 | 1047.00 | 206.88 |
| PBIDT | 6233.00 | 4886.00 | 27.57 | 24656.00 | 17417.00 | 41.56 | 24656.00 | 17417.00 | 41.56 |
| Interest | 88.00 | 45.00 | 95.56 | 196.00 | 145.00 | 35.17 | 196.00 | 145.00 | 35.17 |
| PBDT | 6145.00 | 4841.00 | 26.94 | 24460.00 | 17272.00 | 41.62 | 24460.00 | 17272.00 | 41.62 |
| Depreciation | 937.00 | 516.00 | 81.59 | 2200.00 | 1719.00 | 27.98 | 2200.00 | 1719.00 | 27.98 |
| PBT | 5208.00 | 4325.00 | 20.42 | 22260.00 | 15553.00 | 43.12 | 22260.00 | 15553.00 | 43.12 |
| TAX | 927.00 | 834.00 | 11.15 | 3756.00 | 2487.00 | 51.03 | 3756.00 | 2487.00 | 51.03 |
| Deferred Tax | -67.00 | -2.00 | 3250.00 | -319.00 | -361.00 | -11.63 | -319.00 | -361.00 | -11.63 |
| PAT | 4281.00 | 3491.00 | 22.63 | 18504.00 | 13066.00 | 41.62 | 18504.00 | 13066.00 | 41.62 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 53.85 | 50.64 | 6.34 | 60.22 | 48.80 | 23.39 | 60.22 | 48.80 | 23.39 |